StonvexLoading…
StonvexStonvexStonvexCore line items from TCRT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $0.00 | $5.00K | $2.00K | $2.00K |
Operating Income | $-1.01M | $-4.22M | $-3.32M | $-2.13M |
Net Income | $-1.01M | $-4.18M | $-3.28M | $-2.12M |
EPS (Diluted) | $-0.59 | $-2.20 | $-1.84 | $-1.30 |
Total Assets | $1.88M | $2.97M | $3.72M | $4.74M |
Total Liabilities | $595.00K | $813.00K | $921.00K | $1.07M |
Cash & Equivalents | $354.00K | $1.39M | $1.94M | $2.88M |
Free Cash Flow OCF − CapEx | Not available | $-2.97M | $-2.41M | Not available |
Shares Outstanding | 2.38M | 2.35M | 2.21M | 2.07M |